Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Song, Maarja-Liisa Nairismägi, Yurike Laurensia, et al.
Blood (2018) Vol. 132, Iss. 11, pp. 1146-1158
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1720-1748
Open Access | Times Cited: 2250
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 704
Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi, Mengke Niu, Linping Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 444
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin, Chenguang Yu, Vincent F. Vartabedian, et al.
Science (2020) Vol. 369, Iss. 6506, pp. 993-999
Closed Access | Times Cited: 372
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang, Ziyu Dai, Wantao Wu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 347
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 328
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
Matthew J. Reilley, Patricia McCoon, Carl Cook, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 208
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Bei Huang, Xiaoling Lang, Xihong Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 207
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
Jie Xiong, Bowen Cui, Nan Wang, et al.
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 403-419.e6
Open Access | Times Cited: 187
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment
Shiyong Neo, Ying Yang, Julien Record, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1185-1198
Open Access | Times Cited: 170
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1
Ming Yi, Jing Zhang, Anping Li, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 154
SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer
Mohamed Luban Sobah, Clifford Liongue, Alister C. Ward
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 118
Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 107
Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 96
The theory of tumor ecosystem
Xueman Chen, Erwei Song
Cancer Communications (2022) Vol. 42, Iss. 7, pp. 587-608
Open Access | Times Cited: 78
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Therapeutic challenges in peripheral T-cell lymphoma
Yunpeng Luan, Xiang Li, Yunqi Luan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Sanjay De Mel, Susan Swee-Shan Hue, Anand D. Jeyasekharan, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 115
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study
Seok Jin Kim, Jing Quan Lim, Yurike Laurensia, et al.
Blood (2020) Vol. 136, Iss. 24, pp. 2754-2763
Open Access | Times Cited: 105
Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function
Amy J. Petty, Rui Dai, Rosa Lapalombella, et al.
JCI Insight (2021) Vol. 6, Iss. 6
Open Access | Times Cited: 73
IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer
Wenjuan Gao, Huiping Wen, Luyu Liang, et al.
Theranostics (2021) Vol. 11, Iss. 6, pp. 2564-2580
Open Access | Times Cited: 63
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
Qing Li, Liren Zhang, Wenhua You, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 63
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation
Zhiwei Fan, Changyue Wu, Miaomiao Chen, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1041-1053
Open Access | Times Cited: 62
Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
Bocheng Wu, Quaovi H. Sodji, Adegboyega K. Oyelere
Cancers (2022) Vol. 14, Iss. 3, pp. 552-552
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top